ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
43 hedge funds and large institutions have $7.55M invested in Argos Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
-9
Holders Change %
-17.31%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
16
Reduced
12
Closed
12
Calls
$2.44M
Puts
$41K
Net Calls
+$2.4M
Net Calls Change
-$26M
Top Buyers
| 1 |
BlackRock
New York
|
$360K |
| 2 |
Renaissance Technologies
New York
|
$99K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
$57K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$53K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$382K |
